Research progress of CD80 in the development of immunotherapy drugs
CD80 is a molecule that plays an important role in the immune system, especially during T-cell activation, and its ligands are mainly CD28, PD-L1, and CTLA-4. CD80 is expressed on the surface of tumor cells, and it can be used as a molecular target in the process of T-cell anti-tumor immune response...
Saved in:
| Main Authors: | Lanying Li, Lei Yang, DePeng Jiang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1496992/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corrigendum: Research progress of CD80 in the development of immunotherapy drugs
by: Lanying Li, et al.
Published: (2024-12-01) -
Corrigendum: Research progress of CD80 in the development of immunotherapy drugs
by: Lanying Li, et al.
Published: (2024-12-01) -
Association of CD24, CD27, and co-stimulatory molecules CD80 immunological marker expression on B-cells of human peripheral blood with development of celiac disease
by: Rahab Abd-Ali Al-Madany, et al.
Published: (2024-12-01) -
Elevated CD14 in B cells associates with reduced ovarian cancer risk via CD80 + dendritic cell interaction: a multi-omics study
by: Mengyu Zheng
Published: (2025-06-01) -
A multifunctional T-cell engager containing CD80 enhances prostate cancer treatment
by: Disen Nie, et al.
Published: (2025-07-01)